Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels

BACKGROUND AND PURPOSE: Rabeprazole, a proton pump inhibitor (PPIs) is much endorsed to patients with increased gastric acidity. PPIs were accused to have osteoporotic effects on patients who chronically use them. The point of the current investigation was to decide the impact of rabeprazole on oste...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaalan, Aly A.M., El-Sherbiny, Mohamed, El-Abaseri, Taghrid B., Shoaeir, Mohamed Z., Abdel-Aziz, Tarek M., Mohamed, Magda I., Zaitone, Sawsan A., Mohammad, Hala M. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237708/
https://www.ncbi.nlm.nih.gov/pubmed/32477111
http://dx.doi.org/10.3389/fphar.2020.00583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237708/
https://www.ncbi.nlm.nih.gov/pubmed/32477111
http://dx.doi.org/10.3389/fphar.2020.00583

Ejemplares similares